leadf
logo-loader
viewCleveland BioLabs

Cleveland BioLabs highlights entolimod data

Entolimod is a protein which is currently being developed for dual purposes – as a radiation countermeasure and as a cancer treatment.

cancercell.png
The liver is a common site of cancer metastases for many cancers, including cancers of the gastrointestinal tract.

Radiation and oncology immunotherapy specialist Cleveland BioLabs (NASDAQ:CBLI) and Roswell Park Cancer Institute highlighted data has been released which shows its entolimod protein suppresses metastasis

The data was published in the official journal of the United States National Academy of Sciences, based on studies conducted by scientists at RPCI and Cleveland BioLabs.

Entolimod is a protein which is currently being developed for dual purposes – as a radiation countermeasure and as a cancer treatment.

It supresses metastasis, which, in this case, is the spread of a cancer from one organ or part to another not directly connected with it.

Entolimod induces chemokines that attract NK cells to the liver, which then work as an “antitumor”.

Importantly, antitumor effects in the liver combine with responses in the body to supress the spread of the disease to the lung.

The liver is a common site of cancer metastases for many cancers, including cancers of the gastrointestinal tract. 

Andrei Gudkov, chief scientific officer of Cleveland BioLabs, said: "These observations have elucidated the mechanisms of entolimod's immunotherapeutic activity”.

“This work suggests that entolimod enables vaccination against tumor cells residing in the liver through a mechanism that does not require identification of a particular tumor antigen."

Quick facts: Cleveland BioLabs

Price: 2.05 USD

NASDAQ:CBLI
Market: NASDAQ
Market Cap: $26.68 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Melkior Resources signs earn in deal with Kirkland Lake Gold as they look to...

Melkior Resources (CVE: MKR-OTC: MKRIF) CEO Jonathon Deluce joined Steve Darling from Proactive Vancouver with news the company has announced a strategic partnership with Kirkland Lake Gold. Deluce telling Proactive about the deal and why Kirkland Lake was such a good fit. Deluce also shared...

1 hour, 14 minutes ago

2 min read